Navigation Links
Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program
Date:1/6/2009

nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

Forward-Looking Statement

This press release contains forward-looking statements that are subject to risks and uncertainties, and includes statements that are not historical facts. Actual results could differ significantly from results discussed. Sequella disclaims any intent or obligation to update forward-looking statements, except as required by law.


'/>"/>
SOURCE Sequella, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
2. Tibotec Data Presented at ICAAC and HIV9 Follow Key Regulatory Approvals for Anti-HIV Compounds
3. Portola Announces Data Presentations Relevant to Its Lead Phase II Antithrombotic Compounds at American Heart Association Scientific Sessions 2008
4. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
5. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
6. Novel Compound Shows Promise for Treatment of Alcoholism
7. Volcanos VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKlines Novel Investigational Compound, Darapladib
8. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
9. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
10. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
11. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...portlinker.comannouncesthatanewmarketresearchrepor...-GlobalTrends ,, http://www.reportlinker.com..., Widespreadavailabilityofgenericdrugs,emergence...acceleratedthepaceofgrowthinthepainmanagementmarke...uetoshapedemandforservices,drugsanddevices.Themark...
(Date:11/25/2009)...25/PRNewswire-FirstCall/--HeartWareInternational,I...videroflessinvasive,miniaturizedcirculatorysupport...eartfailure,todayannouncedthatitisscheduledtomakea...althCareConferenceat8:00amESTonWednesday,December2...tel,December1-2. ,, AlivewebcastoftheCompany,sp...
(Date:11/24/2009)...- ,, WHAT:RomHoubens,aBelgianmanthoughttohavebe...llyfullyconsciousandawakeduringthattimeandwasthesu...wasfeaturedinthesegmenttoillustratehowpeoplewithLo...ation. ,, WHEN:GoodMorningAmerica-- Tuesday,Nov... ,, WHO:RomHoubenswasanengineeringstudentin19...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Ewen Callaway named 2009 APS Plant Pathology Journalism awardee 9725 1Ewen Callaway named 2009 APS Plant Pathology Journalism awardee 9725 2Summit VetPharm Helps Veterinarians Protect Against Product Diversion Counterfeiting and Shrinkage Using Vectra 28R 29 Bloodhound 28R 29 Technology 55609 1Summit VetPharm Helps Veterinarians Protect Against Product Diversion Counterfeiting and Shrinkage Using Vectra 28R 29 Bloodhound 28R 29 Technology 55609 2Summit VetPharm Helps Veterinarians Protect Against Product Diversion Counterfeiting and Shrinkage Using Vectra 28R 29 Bloodhound 28R 29 Technology 55609 3Sun Pharmaceutical Files HSR Application for Taro Tender Offer 55606 1Sun Pharmaceutical Files HSR Application for Taro Tender Offer 55606 2Sun Pharmaceutical Files HSR Application for Taro Tender Offer 55606 3
(Date:11/25/2009)... , Does stress increase blood pressure? This sim...h for many years. New Stress-related gene Modulat... increase blood pressure? This simple question ha...s. Now new research has for the first time establ...the blood pressure response to stress in mice as w...
(Date:11/25/2009)... , Evaluation and treatme... Woodstock (Vocus) November 25, 2009 ...1N1 nasal vaccines and H1N1 vaccine shots at four ...nce another shipment of vaccine has arrived. The c...stal Lake and McHenry and will be open as follows:...
(Date:11/25/2009)... On more positive note, CDC sees few signs of tro...AY, Nov. 25 (HealthDay News) -- The ongoing H1N1 s... dangerous pneumonias among younger patients, a U....eing an increase in serious pneumococcal infection... of the National Center for Immunization and Respi...
(Date:11/25/2009)... ,, LittleImprovementShownforthe4thStraigh...ire/-- Today,LungCancerAlliance-Georgia(LCA-GA)is...tisanassessmentofprogressbeingmadeagainstthisletha...CancerAlliance(LCA),theonlynationalorganizationded...plelivingwithoratriskforlungcancer. ,, (Logo: h...
(Date:11/25/2009)... , The serious behavior problems that can occur i...be reduced with a treatment plan that includes med...m for parents, according to Yale University resear...December 2009 issue of the Journal of the America... study was conducted by the National Institute of ...
Breaking Medicine News(10 mins):Health News:New stress-related gene modulates high blood pressure in mice and men 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:Swine Flu Tied to Rise in Pneumonias Among Young 2Health News:Swine Flu Tied to Rise in Pneumonias Among Young 3Health News:Swine Flu Tied to Rise in Pneumonias Among Young 4Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Parent training key to improved treatment of behavior problems in children with autism 2
...rt-term courses of antipsychotic medications are m...o do not take the drugs, according to a report in ... one of the JAMA/Archives journals. , Newer antip...avioral and psychological symptoms of dementia, th...
...imaging to current risk-assessment protocols may i...heart disease, UT Southwestern Medical Center rese...the UT Southwestern-led Dallas Heart Study to dete...art disease and who could benefit from cholesterol...
...th disease-free survival up to 5 years , ,...eatment for early vocal-cord cancer targets tumor ...nts, voices, according to Massachusetts General Ho...osphate (KTP) laser treatment, which has been used...
...5-7 Confirms: No Lead in Desso ...cently, media have been,reporting about the allege... The fields in question are not manufactured by De...c turf products and complete systems have been tes...
...s important to make healthy choices , , MO...s the start of the summer holiday season, so it,s ...rom your diet, cautions Elizabeth Schaub, a dietit...hoices. , Schaub offers the following tips: , Or...
... up the clumps of mutant protein that drive neurod...ity researchers engineered a virus to make an intr...in, the protein whose mutant forms poison the brai...imbs, although it does not prolong their lives. , ...
Other Medicine News:Health News:Short-term use of antipsychotics in older adults with dementia linked to serious adverse events 2Health News:Increased screening may better predict those at higher risk for heart disease, researchers report 2Health News:Laser Therapy a New Option for Vocal-Cord Cancers 2Health News:It's Safe to Play on Desso Synthetic Turf 2Health News:It's Safe to Play on Desso Synthetic Turf 3Health News:Don't Leave Diet Out to Lunch on Vacation 2Health News:'Intrabody' can mop up mutant protein in Huntington's disease model 2
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
...l reference laboratory and a worldwide leader in i...P offers an extensive test menu of highly complex ...pathology. Owned by the University of Utah, ARUP L... nation's university teaching hospitals and childr...
Medicine Products: